EN PL
CASE REPORT
Lung tuberculosis in a patient suffering from granulomatosis with polyangiitis (Wegener's granulomatosis) and receiving immunosuppressive treatment
 
More details
Hide details
 
Online publication date: 2013-04-29
 
 
Reumatologia 2013;51(2):156-160
 
KEYWORDS
ABSTRACT
Granulomatosis with polyangiitis (Wegener's granulomatosis) is a systemic disease caused the ensuing necrosis and granuloma formation. Contrary to tuberculosis, the aetiology of the disease is not known. Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. Despite different aetiology, clinical symptoms in pa­tients suffering from granulomatosis with polyangiitis or from tuberculosis are often similar and this may cause diagnostic problems. The problem becomes more difficult due to the fact that tuberculosis infection can induce formation of antibodies, e.g. anti-neutrophil cytoplasmic antibodies (ANCAs), which are used as markers in the diagnosis of other diseases including vasculitis.
In the paper the authors describe the case of a patient suffering from granulomatosis with polyangiitis, whose latent tuberculosis infection progressed to tuberculosis disease while undergoing immunosuppressive treatment.
 
REFERENCES (23)
1.
Sherkat R, Mostafavizadeh K, Zeydabadi L, et al. Antineutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis. Iran J Immunol 2011; 8: 52-57.
 
2.
Word Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2010 Geneva, Switzerland: WHO 2010. .
 
3.
Jasmer RM, Bozeman L, Schwartzman K, et al. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? Am J Respir Crit Care Med 2004; 170: 1360-1366.
 
4.
Szczuka I. Epidemiologia gruźlicy. Zakład Epidemiologii i Organizacji Walki z Gruźlicą Instytut Gruźlicy i Chorób Płuc (www.igichp.edu.pl).
 
5.
Beuidenhout J, Schneider JW. Pathology and pathogenesis of tuberculosis. In: Tuberculosis, Schaaf HS, Zumla AI (ed.). WB Saunders, London 2009; 117-128.
 
6.
Maher D. The natural history of Mycobacterium tuberculosis infection in adults. In: Tuberculosis, Schaaf HS, Zumla AI (ed.). WB Saunders, London 2009; 129-132. .
 
7.
Bartalesi F, Vicidomini S, Goletti D, et al. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 2009; 33: 586-593. .
 
8.
Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-1107. .
 
9.
Wallis RS, Broder MS, Wong JY, et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004; 38: 1261-1265.
 
10.
Cisneros JR, Murray KM. Corticosteroids in tuberculosis. Ann Pharmacother 1996; 30: 1298-1303.
 
11.
Jakóbisiak M. Główne komponenty i zasadnicze cechy odpowiedzi immunologicznej. W: Immunologia. Głąb J (red.). Wydawnictwo Naukowe PWN, Warszawa 2008; 1-5. .
 
12.
Lyu J, Lee S-G, Hwang S, et al. Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates. Liver Transpl 2011; 17: 963-968.
 
13.
Szczeklik A. Choroby wewnętrzne. Stan wiedzy na rok 2011. Medycyna Praktyczna, Kraków 2011; 1774-1777. .
 
14.
Belostotsky VM, Shah V, Dillon MJ. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 2002; 17: 754-761. .
 
15.
Horn RG, Fauci AS, Rosenthal AS, Wolff SM. Renal biopsy pathology in Wegener's granulomatosis. Am J Pathol 1974; 74: 423-440. .
 
16.
Prakash UBS, Sttubs SE. Optimal bronchoskopy. In: Bronchoscopy, Prakash UBS (ed.). Raven Press, New York 1994: 415-431. .
 
17.
Podręcznik gruźlicy. Zalecenia NPZG. Instytut Gruźlicy i Chorób Płuc. Warszawa 2001; 17-19.
 
18.
Brihaye B, Aouba A, Pagnoux C, et al. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients. Clin Exp Rheumatol 2007; 25: 23-27.
 
19.
Jayne D. Review article: Progress of treatment in ANCA-associated vasculitis. Nephrology 2009; 14: 42-48.
 
20.
Lapraik C, Watts R, Bacon P, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 2007; 46: 1615-1616.
 
21.
Kucharz E, Korzeniewska-Koseła M, Kotulska A. Zalecenia postępowania w zapobieganiu i leczeniu gruźlicy u chorych leczonych antagonistami TNF-. Reumatologia 2008; 46: 51-54. .
 
22.
Flores-Suárez LF, Cabiedes J, Villa AR, et al. Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis. Rheumatology (Oxford) 2003; 42: 223-229.
 
23.
Teixeira L, Mahr A, Jaureguy F, et al. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis. Rheumatology (Oxford) 2005; 44: 247-250.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top